CNS: Hippocampal-avoidance WBRT
Free question published 31 October 2026
A 64-year-old woman with metastatic breast cancer has multiple small brain metastases not amenable to stereotactic radiosurgery. She has good performance status (KPS 80) and an estimated survival of several months, and is concerned about memory. The team plans whole-brain radiotherapy. Which approach best preserves cognitive function?
- AWhole-brain radiotherapy plus prophylactic levetiracetam
- BWhole-brain radiotherapy 30 Gy in 10 fractions with no hippocampal sparing or memantine
- COptimal supportive care with dexamethasone and no radiotherapy
- DHippocampal-avoidance whole-brain radiotherapy alone, omitting memantine
- EHippocampal-avoidance whole-brain radiotherapy plus memantine
Why E is correct
NRG Oncology CC001 (Brown, JCO 2020) randomised patients with brain metastases to hippocampal-avoidance whole-brain radiotherapy plus memantine versus standard WBRT plus memantine. Hippocampal avoidance significantly reduced the risk of cognitive failure (adjusted hazard ratio 0.74) without compromising intracranial control or survival. For a fit patient needing WBRT and worried about cognition, HA-WBRT with memantine is the preferred technique.
And why the others are not
- AIncorrect: levetiracetam is an antiepileptic and does not address radiation-related cognitive decline.
- BIncorrect: standard WBRT without hippocampal sparing carried a higher risk of cognitive failure in CC001.
- CIncorrect: this fit patient with multiple metastases not suitable for SRS has an indication for WBRT, not supportive care alone.
- DIncorrect: both arms of CC001 received memantine; omitting it removes an established neuroprotective agent.
Source NRG Oncology CC001 — hippocampal-avoidance whole-brain radiotherapy plus memantine for brain metastases — Brown PD, Gondi V, Pugh S, et al. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol. 2020;38(10):1019-1029.
More free central nervous system questions
- CNS: Meningioma observation · 20 October 2026
- CNS: Post-operative cavity SRS · 11 November 2026
- CNS: WHO 2021 molecular classification · 09 October 2026
Sitting in February? Follow the twenty-week plan.
2,500+ cited questions like this one are waiting in the vault.
See plans and pricing